Glenmark Pharmaceuticals settled allegations that it conspired to fix prices on generic prescription drugs by agreeing to pay $29.6 million to 48 states (announced July 15, 2026)—plus a separate $37.8 million settlement covering hospitals, pharmacies, and pharmacy benefit managers. If you bought certain generic antibiotics, diabetes medications, or cholesterol drugs during the settlement period, you may be eligible to claim a refund. The settlement covers generic doxycycline hyclate, glyburide, and pravastatin purchased between May 1, 2009, and December 31, 2019. Consumer registration has opened, but the formal claim process and refund amounts have not yet been finalized.
Official resources:
- Read the official notice from Attorneygeneral — Use this primary source to verify the official announcement.
- Read the official notice from Justice — Use this primary source to verify the official announcement.
Table of Contents
- What Drugs and Time Period Does the Settlement Cover?
- Who Can Claim and How Do You Register?
- What Will Refund Amounts Be?
- Current Status and Timeline
- The Criminal Settlement Behind the Civil Case
- Frequently Asked Questions
What Drugs and Time Period Does the Settlement Cover?
The settlement covers three generic medications that Glenmark manufactured: doxycycline hyclate (a broad-spectrum antibiotic used for bacterial infections), glyburide (a diabetes treatment), and pravastatin (a cholesterol-lowering drug). The alleged price-fixing conspiracy ran from May 1, 2009, through December 31, 2019—nearly 11 years.
If you filled prescriptions for these generic drugs during that window, even if you bought them from a pharmacy rather than directly from Glenmark, you may have been affected by inflated prices. The exact list of affected generic versions and any related medications has not been publicly detailed, so checking your prescription records for these three drug names during the settlement period is the practical first step.
Who Can Claim and How Do You Register?
You are eligible to claim if you personally purchased any of the three affected generic drugs during the settlement period—as an end-consumer, not as an institution. Hospitals, pharmacies, and pharmacy benefit managers are covered under the separate $37.8 million direct purchaser settlement, so individual consumers use this claim process.
Registration is currently open at www.AGGenericDrugs.com or by calling 1-866-290-0182. Registration at this stage is a notification step; when you register, you will receive updates about when the actual claims form becomes available. You do not need to file a detailed claim yet.
What Will Refund Amounts Be?
Individual refund amounts, the claim procedure details, and the exact deadline remain to be determined as the settlement administration process unfolds. The settlement fund totals $29.6 million before legal fees and administration costs, which means the per-person refund will depend on how many valid claims are filed.
If you purchased these drugs regularly during the decade-long settlement period, your refund may be larger than a one-time prescription purchase. However, without knowing the final number of claimants, calculating your potential refund is not yet possible. The settlement administrator will provide a refund calculator or specific guidance once the claims process launches.
Current Status and Timeline
The formal consumer claim process has not yet been launched, and registration is notification-only. The settlement was announced July 15, 2026, and a claims deadline of November 9 is pending final settlement administration coordination—meaning that date may shift.
To stay informed, register now at www.AGGenericDrugs.com so you receive direct notice when claims open. Do not wait for a mailed notice or email solicitation; proactive registration ensures you will not miss the deadline once it is confirmed.
The Criminal Settlement Behind the Civil Case
Glenmark admitted in a separate Department of Justice case that it conspired with another drug maker, Apotex, to fix pravastatin prices from May 2013 through December 2015. The company agreed to a deferred prosecution agreement, paying $30 million in criminal penalties and $25 million to settle alleged False Claims Act violations related to inflated prices charged to federal healthcare programs. This criminal case formed part of the basis for the broader state-level civil settlement announced in July 2026.
Frequently Asked Questions
Do I need a receipt to claim?
The settlement administrator will specify documentation requirements once the claims form launches. Gather pharmacy records, insurance explanations of benefits, or credit card statements showing the three drug names and purchase dates as backup, but wait for official guidance on what is required.
Can I claim if I bought these drugs for a family member?
Only direct purchasers—people who actually bought or paid for the drugs—are eligible. If you purchased on behalf of a dependent, you may be the eligible claimant, but institutional bulk purchases do not qualify.
What if I bought generic versions under different brand names?
The settlement covers generic versions of doxycycline hyclate, glyburide, and pravastatin by any manufacturer. The brand name does not matter; register and provide the drug's generic name and purchase dates.